Home / Industry Reports / Non Small Cell Lung Cancer Market Research
Sort By: Title Date Price

Tarceva (Non Small Cell Lung Cancer) Analysis and Forecasts to 2015

GlobalDatas pharmaceuticals report, Tarceva (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2020 provides Tarceva sales forecasts for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2004-2020). The report also includes information on Non Small Cell Lung Cancer market.

$2000 Read More

Gemzar (Non Small Cell Lung Cancer) Analysis and Forecasts to 2015

GlobalDatas pharmaceuticals report, Gemzar (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2015 provides Gemzar sales forecasts for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002- 2015). 

$2000 Read More

Non-Small Cell Lung Cancer Market Research Reports

Non-Small Cell Lung Cancer is a common kind of lung cancer that generally occurs in women and men. Approximately about eighty five percent to ninety percentage of lung cancers are Non-Small Cell Lung Cancer. As per the statistical data, the worldwide Non-Small Cell Lung Cancer drug market will make a steep increase in market revenue raising its output from four billion US dollars to seven billion US dollars within the forecasting period 2009-2019 with a CAGR growth rate reaching 5 % of growth.

Although Non-Small Cell Lung Cancers are generally related with events like cigar smoke or nicotine smoke, adenocarcinomas is a kind of disease that may be found in the patients who have never smoked it or are passive smokers. The Non-Small Cell Lung Cancer drugs market will experience growth and expansion due to different factors like sedentary life style, cigarette smoking and several other agents that are randomly released in atmosphere as asbestos and radon.

The market projections that the Non-Small Cell Lung Cancer drug sector will continue its upward trend, resulting in a rising uneven market industry through customized medications by the end of the year 2019. Such a high growth prediction is attributed to aspects such as rising population, powerful pipeline scenario and release of brand new effective drugs with better efficiency and security.

Are you worried about taking quiet decisions related to lung cancer treatment or are you trying to restore your good health after the treatment. Then our market research reports based on Non-Small Cell Lung Cancer will guide you in shaping your business decisions by providing in depth information with detailed analysis of the received market data. This will lead to your growth in business & reputation, expansion, progress and prosperity.